S22-015 Amyloid-binding Peptoids with Broad-spectrum Antiviral, Antibacterial, and Antifungal Activity Background Annelise Barron John Fortkort Jevgenij Raskatov Michael Rae
S19-058 Modulating Bone Morphogenic Protein (BMP) Signaling in the Treatment of Alzheimer's Disease Technology Reference Stanford ref. no S19-058 CZ Biohub ref. no. CZB-179S Researchers at Stanford University have described a novel therapeutic target for Alzheimer's disease. Michael Clarke Jane Antony Maddalena Adorno Felicia Reinitz Benedetta di Robilant Elizabeth Chen
S10-337 Potent MET receptor agonists and antagonists Stanford Reference: Dockets S10-337 and S10-337B: Jennifer Cochran Douglas Jones Ping-Chuan Tsai
S20-306 Understanding theta oscillations' role in driving empathy in psychiatric conditions and Alzheimer's disease Researchers in the Lee lab have discovered a totally novel approach to restore the impairment of empathy associated with many neurological disorders and mental illnesses. Jin Hyung Lee Hee-Sup Shin